comparemela.com

Latest Breaking News On - Arthurc corcoran - Page 1 : comparemela.com

Idorsia Pharmaceuticals Ltd: New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the European Society of Hypertension Annual Meeting 2023

Idorsia Pharmaceuticals Ltd: New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the European Society of Hypertension Annual Meeting 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the European Society of Hypertension Annual Meeting 2023

Allschwil, Switzerland – June 26, 2023 Idorsia Ltd (SIX: IDIA) today announced that further data for aprocitentan, Idorsia’s investigational dual endothelin receptor antagonist evaluating the treatment of patients with resistant hypertensio.

Idorsia Pharmaceuticals Ltd: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202

Idorsia Pharmaceuticals Ltd: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.